Agentic AI-EnableD CardioVascular CAre TransfOrmation (ADVOCATE) Innovative Solutions Opening (ISO)

SolicitationActive

Puntos Clave

  • 43 días hasta la fecha límite de respuesta
  • Competencia abierta completa - todas las empresas pueden participar
  • Trabajo a realizarse en Washington, DC
  • Industria: Research and Development in Biotechnology (except Nanobiotechnology)

Detalles del Contrato

ID de Aviso
ARPA-H-SOL-26-142
Tipo de Oportunidad
Solicitation
Sub-Agencia
NATIONAL INSTITUTES OF HEALTH
Oficina
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Fecha de Publicación
Tuesday, January 13, 2026
Fecha Límite de Respuesta
Wednesday, April 1, 2026
Código PSC
AN13
Reserva
Competencia Abierta Completa
Lugar de Desempeño
Washington, DC, 20005
Estado
Activo

Descripción

The Advanced Research Projects Agency for Health (ARPA-H) Agentic AI-Enabled Cardiovascular Care Transformation (ADVOCATE) program will enable the development of an Agentic system that delivers autonomous and semi-autonomous clinical care directly to patients with cardiovascular disease (CVD). Interested parties are invited to review the attached ADVOCATE Innovative Solutions Opening (ISO) ARPA-H -SOL-26-142. For detailed information regarding the ADVOCATE Proposers' Day, review Special Notice (SN) ARPA-H-SN-26-139.

Por Qué Importa Esta Oportunidad

HEALTH AND HUMAN SERVICES, DEPARTMENT OF está buscando activamente contratistas calificados para research and development in biotechnology (except nanobiotechnology) en Washington, DC.